Cell Reports Medicine

Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis

By Federica Tavaglione, Rohit Seth Loomba

Graphical abstract from Cell Reports Medicine — Graphical abstract. Tavaglione et al.

ReviewInterventions

The paper

Federica Tavaglione, Rohit Seth Loomba

University of California San Diego

Cell Reports Medicine, 4 Sep 2026

doi.org/10.1016/j.xcrm.2026.103023 PubMed 42697203

The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial